AstraZeneca plc vs Five9 Inc — how do they compare? AstraZeneca plc trades at $157.5 (market cap $245.16B), while Five9 Inc trades at $33.74 (market cap $2.33B). The key difference: AstraZeneca plc is far larger — about 105.2× Five9 Inc's market cap, and AstraZeneca plc pays a 2.02% dividend while Five9 Inc pays none. Which is the better fit depends on your goals.
| AZN | FIVN | |
|---|---|---|
Market Cap | $245.16B | $2.33B |
Sector | Health | Technology |
52-Week High | $209.48 | $34.48 |
52-Week Low | $147.06 | $13.61 |
Enterprise Value | $272.43B | $2.48B |
Dividend Yield | 2.02% | — |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →